Anna Rajab1, Markus Schuelke2, Esther Gill3, Angelika Zwirner4, Franziska Seifert3, Susanne Morales Gonzalez3, Ellen Knierim2. 1. Genetic Unit, Royal Hospital, Ministry of Health, Muscat, Sultanate of Oman. 2. NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany Department of Neuropediatrics, Charité-Universitätsmedizin Berlin, Berlin, Germany. 3. NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany. 4. Department of Neuropediatrics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Abstract
BACKGROUND: Various genetic defects cause autism associated with intellectual disability and epilepsy. Here, we set out to identify the genetic defect in a consanguineous Omani family with three affected children in whom mutations in known candidate genes had been excluded beforehand. METHODS: For mutation screening, we combined autozygosity mapping and whole exome sequencing. Segregation of potential disease variants with the phenotype was verified by Sanger sequencing. A splice-site mutation was confirmed and quantified by qPCR. RESULTS: We found an autosomal recessive splice acceptor mutation in DEAF1 (c.997+4A>C, p.G292Pfs*) in all affected individuals, which led to exon skipping, and reduced the normal full-length mRNA copy number in the patients to 5% of the wild-type level. Besides intellectual disability and autism, two of three affected siblings suffered from severe epilepsy. All patients exhibited dyskinesia of the limbs coinciding with symmetric T2 hyperintensities of the basal ganglia on cranial MRI. CONCLUSIONS: A recent report has shown dominant DEAF1 mutations to occur de novo in patients with intellectual disability. Here, we demonstrate that a DEAF1-associated disorder can also be inherited as an autosomal recessive trait with heterozygous individuals being entirely healthy. Our findings expand the clinical and genetic spectrum of DEAF1 mutations to comprise epilepsy and extrapyramidal symptoms. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Various genetic defects cause autism associated with intellectual disability and epilepsy. Here, we set out to identify the genetic defect in a consanguineous Omani family with three affected children in whom mutations in known candidate genes had been excluded beforehand. METHODS: For mutation screening, we combined autozygosity mapping and whole exome sequencing. Segregation of potential disease variants with the phenotype was verified by Sanger sequencing. A splice-site mutation was confirmed and quantified by qPCR. RESULTS: We found an autosomal recessive splice acceptor mutation in DEAF1 (c.997+4A>C, p.G292Pfs*) in all affected individuals, which led to exon skipping, and reduced the normal full-length mRNA copy number in the patients to 5% of the wild-type level. Besides intellectual disability and autism, two of three affected siblings suffered from severe epilepsy. All patients exhibited dyskinesia of the limbs coinciding with symmetric T2 hyperintensities of the basal ganglia on cranial MRI. CONCLUSIONS: A recent report has shown dominant DEAF1 mutations to occur de novo in patients with intellectual disability. Here, we demonstrate that a DEAF1-associated disorder can also be inherited as an autosomal recessive trait with heterozygous individuals being entirely healthy. Our findings expand the clinical and genetic spectrum of DEAF1 mutations to comprise epilepsy and extrapyramidal symptoms. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Li Chen; Philip J Jensik; Joseph T Alaimo; Magdalena Walkiewicz; Seth Berger; Elizabeth Roeder; Eissa A Faqeih; Jonathan A Bernstein; Ann C M Smith; Sureni V Mullegama; David W Saffen; Sarah H Elsea Journal: Hum Mutat Date: 2017-09-23 Impact factor: 4.878
Authors: Wei-Chao Huang; Elliott Ferris; Tong Cheng; Cornelia Stacher Hörndli; Kelly Gleason; Carol Tamminga; Janice D Wagner; Kenneth M Boucher; Jan L Christian; Christopher Gregg Journal: Neuron Date: 2017-02-23 Impact factor: 17.173
Authors: Tamar Harel; Gozde Yesil; Yavuz Bayram; Zeynep Coban-Akdemir; Wu-Lin Charng; Ender Karaca; Ali Al Asmari; Mohammad K Eldomery; Jill V Hunter; Shalini N Jhangiani; Jill A Rosenfeld; Davut Pehlivan; Ayman W El-Hattab; Mohammed A Saleh; Charles A LeDuc; Donna Muzny; Eric Boerwinkle; Richard A Gibbs; Wendy K Chung; Yaping Yang; John W Belmont; James R Lupski Journal: Am J Hum Genet Date: 2016-03-03 Impact factor: 11.025
Authors: Calvin P Sjaarda; Shalandra Wood; Amy J M McNaughton; Sarah Taylor; Melissa L Hudson; Xudong Liu; Andrea Guerin; Muhammad Ayub Journal: J Hum Genet Date: 2019-12-12 Impact factor: 3.172
Authors: Betsy E P Ostrander; Russell J Butterfield; Brent S Pedersen; Andrew J Farrell; Ryan M Layer; Alistair Ward; Chase Miller; Tonya DiSera; Francis M Filloux; Meghan S Candee; Tara Newcomb; Joshua L Bonkowsky; Gabor T Marth; Aaron R Quinlan Journal: NPJ Genom Med Date: 2018-08-13 Impact factor: 8.617